Literature DB >> 16392790

Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents.

Jason A Wiles1, Akihiro Hashimoto, Jane A Thanassi, Jijun Cheng, Christopher D Incarvito, Milind Deshpande, Michael J Pucci, Barton J Bradbury.   

Abstract

We report the syntheses of first-generation derivatives of isothiazolopyridones and their in vitro evaluation as antibacterial agents. These compounds, containing a novel heterocyclic nucleus composed of an isothiazolone fused to a quinolizin-4-one (at C-2 and C-3 of the quinolizin-4-one), were prepared using a sequence of seven synthetic transformations. The solid-state structure of 7-chloro-9-ethyl-1-thia-2,4a-diazacyclopenta[b]naphthalene-3,4-dione was determined by X-ray diffraction. The prepared derivatives of desfluoroisothiazolopyridones exhibited (a) antibacterial activity against Gram-negative and Gram-positive organisms, (b) inhibitory activities against DNA gyrase and topoisomerase IV, and (c) no inhibitory activity against human topoisomerase II.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16392790     DOI: 10.1021/jm051066d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening.

Authors:  Mahalakshmi Vasan; João Neres; Jessica Williams; Daniel J Wilson; Aaron M Teitelbaum; Rory P Remmel; Courtney C Aldrich
Journal:  ChemMedChem       Date:  2010-12-03       Impact factor: 3.466

Review 2.  A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.

Authors:  Gregory S Bisacchi; Michael R Hale
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

3.  In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.

Authors:  Carmen A Molina-Torres; Jorge Ocampo-Candiani; Adrian Rendón; Michael J Pucci; Lucio Vera-Cabrera
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

4.  Biological and docking studies of topoisomerase IV inhibition by thiosemicarbazides.

Authors:  Agata Siwek; Paweł Stączek; Monika Wujec; Joanna Stefańska; Urszula Kosikowska; Anna Malm; Stefan Jankowski; Piotr Paneth
Journal:  J Mol Model       Date:  2010-11-16       Impact factor: 1.810

Review 5.  Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis.

Authors:  Michael A Reiche; Digby F Warner; Valerie Mizrahi
Journal:  Front Mol Biosci       Date:  2017-11-14

6.  Synthesis and Decarboxylation of Functionalized 2-Pyridone-3-carboxylic Acids and Evaluation of their Antimicrobial Activity and Molecular Docking.

Authors:  Elmira Meghrazi Ahadi; Homa Azizian; Vaezeh Fathi Vavsari; Atousa Aliahmadi; Zeinab Shahsavari; Hamid R Bijanzadeh; Saeed Balalaie
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

7.  Enzymatic synthesis of 2-hydroxy-4H-quinolizin-4-one scaffolds by integrating coenzyme a ligases and a type III PKS from Huperzia serrata.

Authors:  Juan Wang; Ning Ding; Yun Wu; Xiaoping Shi; Bowen Qi; Xiao Liu; Xiaohui Wang; Jun Li; Pengfei Tu; Shepo Shi
Journal:  RSC Adv       Date:  2020-06-22       Impact factor: 4.036

8.  Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-negative Bacteria.

Authors:  Aleksey I Gerasyuto; Michael A Arnold; Jiashi Wang; Guangming Chen; Xiaoyan Zhang; Sean Smith; Matthew G Woll; John Baird; Nanjing Zhang; Neil G Almstead; Jana Narasimhan; Srinivasa Peddi; Melissa Dumble; Josephine Sheedy; Marla Weetall; Arthur A Branstrom; J V N Prasad; Gary M Karp
Journal:  J Med Chem       Date:  2018-05-14       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.